This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.

 

This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Athena Philis-Tsimikas
Dr Athena
Philis-Tsimikas
Corporate Vice President Scripps Whittier Diabetes Institute, San Diego, USA

Dr Athena Philis-Tsimikas, a board-certified endocrinologist, is Corporate Vice President of the Scripps Whittier Diabetes Institute at Scripps Health and Director of Community Engagement for the Clinical Translational Science Award, housed at Scripps Research Translational Institute in San Diego, USA (1UL1 TR002550-03, Topol PI). With over 25 years of experience, she has served as a member of the Scripps Clinic Medical Group in the division of endocrinology and diabetes and leads the diabetes care line for Scripps Health, which creates programmes, conducts research and delivers diabetes services across five Scripps hospitals, 25 outpatient facilities and the community.

 

She is a leader of the innovative Project Dulce and Dulce Digital programme, which cares for underserved populations with diabetes. Dr Philis-Tsimikas and Scripps Whittier Diabetes Institute are actively promoting participation of health centres in community-based clinical research, with a focus on integrating digital technologies to improve diabetes care in the ambulatory and hospital setting. 

 

A complete list of her peer-reviewed publications can be found here: https://pubmed.ncbi.nlm.nih.gov/?term=philis-tsimikas+a

Speaker - Monika Kellerer

Professor Monika Kellerer

Department of Diabetology and Endocrinology, Angiology, Intensive Care Unit, Cardiology Marienhospital Stuttgart, Stuttgart, Germany


Professor Dr Monika Kellerer is Professor of Internal Medicine and Director of the Department of Diabetology, Endocrinology, Angiology, Intensive Care Unit and Cardiology at Marienhospital Stuttgart, a teaching hospital of the University of Tübingen, Germany.

 

She earned her MD degree from Ludwig-Maximilians University, Munich, Germany and her PhD (habilitation thesis) from Eberhard Karls University, Tübingen, Germany. She completed a post-doctoral fellowship at the Joslin Diabetes Center, Harvard Medical School, Boston, USA. She is board certified in endocrinology, diabetology and internal medicine by the German Physician Board.

 

She is 2021–2023 Senior President and Guideline Coordinator of the German Diabetes Association (DDG), and a member of the DDG board on scientific statements and healthcare policy. Her research interests are clinical diabetology, the insulin signalling mechanism, specific effects of insulin analogues, mechanisms of lipotoxicity and beta cell dysfunction. She is also involved in clinical research for diabetes as a national lead investigator.

 

She is the recipient of prestigious awards including the Förderpreis of the DDG (1992), the Ferdinand Bertram Award (1996) and the Helmut Otto Medal (2015). She has published numerous articles in medical literature and is the author or co-author of several books and book chapters in the field of diabetes.


Read full bio